• SKIP TO CONTENT
  • SKIP NAVIGATION
  • Patient Resources
    • COVID-19 Patient Resource Center
    • Clinical Trials
    • Search Clinical Trials
    • Patient Notification System
    • What is Clinical Research?
    • Volunteering for a Clinical Trial
    • Understanding Informed Consent
    • Useful Resources
    • FDA Approved Drugs
  • Professional Resources
    • Research Center Profiles
    • Clinical Trial Listings
    • Market Research
    • FDA Approved Drugs
    • Training Guides
    • Books
    • eLearning
    • Events
    • Newsletters
    • White Papers
    • SOPs
    • eCFR and Guidances
  • White Papers
  • Trial Listings
  • Advertise
  • COVID-19
  • iConnect
  • Sign In
  • Create Account
  • Sign Out
  • My Account
Home » Trial Masters and Zeincro merge to create specialist CRO in South-Eastern Europe

Trial Masters and Zeincro merge to create specialist CRO in South-Eastern Europe

June 14, 2012
CenterWatch Staff

ZeinCRO, a specialist provider of clinical research services in Greece, Turkey and Cyprus, is merging with Trial Masters, a CRO managing clinical trials in Hungary and Romania.

With a team of more than 140 people and over a decade’s experience, the expanded ZeinCRO Group will be ideally positioned to offer to its global drug development customers clinical trial services in a broader geographical region in Central and South- Eastern Europe (CSEE).

“Adding Trial Masters to ZeinCRO Group will extend our geographic reach and allow us to work on larger-scale projects,” said Gregory Sivolapenko, chairman of ZeinCRO Group. “Both our teams have forged strong links with local authorities and the healthcare community, giving us a unique and in-depth understanding of the regions in which we operate and enabling us to deliver bespoke clinical research services that are flexible and ethical, maximizing patient recruitment and compliance.”

Supplementary to clinical research services in CSEE, ZeinCRO Group provides specialized services in risk management plans, pharmacovigilance, post-marketing safety and efficacy studies as well as regulatory affairs.

Dr. János Demeter, CEO of Trial Masters, added, “We are excited to be joining ZeinCRO Group. This is a natural fit as we both share the same core values and fundamental approach to successfully delivering clinical development programs. As we continue our local presence but also become part of a larger organization, we will be able to enhance the support we offer to our customers.”

Upcoming Events

  • 16Feb

    Fundamentals of FDA Inspection Management: Reduce Anxiety, Increase Inspection Success

  • 21May

    WCG MAGI Clinical Research Conference – 2023 East

Featured Products

  • Spreadsheet Validation: Tools and Techniques to Make Data in Excel Compliant

    Spreadsheet Validation: Tools and Techniques to Make Data in Excel Compliant

  • Surviving an FDA GCP Inspection

    Surviving an FDA GCP Inspection: Resources for Investigators, Sponsors, CROs and IRBs

Featured Stories

  • SurveywBlueBackground-360x240.png

    Sites Name Tech Acceptance as Essential Factor in Selection of Sponsors, Survey Finds

  • TrendsInsights2023-360x240.png

    WCG Clinical Research Trends and Insights for 2023, Part Two

  • TimeMoneyEffort-360x240.png

    Time is Money and So Is Effort, Budgeting Experts Say

  • TrendsInsights2023A-360x240.png

    WCG Clinical Research Trends and Insights for 2023, Part Three

Standard Operating Procedures for Risk-Based Monitoring of Clinical Trials

The information you need to adapt your monitoring plan to changing times.

Learn More Here
  • About Us
  • Contact Us
  • Privacy Policy
  • Do Not Sell or Share My Data

Footer Logo

300 N. Washington St., Suite 200, Falls Church, VA 22046, USA

Phone 617.948.5100 – Toll free 866.219.3440

Copyright © 2023. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing